Fundamentals

Cytomed Therapeutics Ltd

GDTC

Soon

Sentiment

Soon

Options

Revenue

0.00

0.000.00%

-

Assets

12.37M

▲7.14M▲136.63%

12 Months Change

Liabilities

1.12M

▼-3.52M▼-75.76%

12 Months Change

Free Cash Flow

-3.49M

▼-1.62M▼-86.47%

12 Months Change

Revenue/Cost Of Revenue

Quarterly

Net Profit/Loss

Quarterly

Assets/Liabilities

Quarterly

Cash Flows

Quarterly

Quarterly

Outstanding Shares

Quarterly

Recent Quarterly and Annual Filings

ID: 0001493152-24-015594

ID: 0001493152-23-015042